| 1 |
Kuo Y, De S. Development of carbon dots to manage Alzheimer's disease and Parkinson's disease. Journal of the Taiwan Institute of Chemical Engineers 2023;146:104799. [DOI: 10.1016/j.jtice.2023.104799] [Reference Citation Analysis]
|
| 2 |
Ashique S, Afzal O, Yasmin S, Hussain A, Altamimi MA, Webster TJ, Altamimi ASA. Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective. Int J Pharm 2023;633:122614. [PMID: 36646255 DOI: 10.1016/j.ijpharm.2023.122614] [Reference Citation Analysis]
|
| 3 |
da Silva TN, de Lima EV, Barradas TN, Testa CG, Picciani PHS, Figueiredo CP, do Carmo FA, Clarke JR. Nanosystems for gene therapy targeting brain damage caused by viral infections. Mater Today Bio 2023;18:100525. [PMID: 36619201 DOI: 10.1016/j.mtbio.2022.100525] [Reference Citation Analysis]
|
| 4 |
Ding Y, Zhang Y, Liu X. Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia. Front Mol Neurosci 2022;15:1043947. [DOI: 10.3389/fnmol.2022.1043947] [Reference Citation Analysis]
|
| 5 |
Tsakiri M, Zivko C, Demetzos C, Mahairaki V. Lipid-based nanoparticles and RNA as innovative neuro-therapeutics. Front Pharmacol 2022;13:900610. [DOI: 10.3389/fphar.2022.900610] [Reference Citation Analysis]
|
| 6 |
Sargazi S, Arshad R, Ghamari R, Rahdar A, Bakhshi A, Karkan SF, Ajalli N, Bilal M, Díez-Pascual AM. siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review. Cell Biol Int 2022. [PMID: 35830711 DOI: 10.1002/cbin.11841] [Reference Citation Analysis]
|
| 7 |
Wang R, Huang S, Zhang Q, Yu X, Hong K, Cao J, Xiao H, Wang Y, Shuai X. Construction of Magnetic Resonance Imaging Visible Polymeric Vector for Efficient Tumor Targeted siRNA Delivery. Chin J Polym Sci. [DOI: 10.1007/s10118-022-2794-1] [Reference Citation Analysis]
|
| 8 |
Ashique S, Almohaywi B, Haider N, Yasmin S, Hussain A, Mishra N, Garg A. siRNA-based nanocarriers for targeted drug delivery to control breast cancer. Advances in Cancer Biology - Metastasis 2022;4:100047. [DOI: 10.1016/j.adcanc.2022.100047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Ashique S, Upadhyay A, Kumar N, Chauhan S, Mishra N. Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery- A review. Advances in Cancer Biology - Metastasis 2022;4:100041. [DOI: 10.1016/j.adcanc.2022.100041] [Reference Citation Analysis]
|
